ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall (PR Newswire via Yahoo! Finance)
ThermoGenesis, Corp. , a leading supplier of innovative products and services that process and store adult stem cells, said today that the FDA has agreed with its plan to remedy the voluntary recall of certain lots of AXP disposable bagsets that it announced in November.

Daiichi, Ranbaxy form joint team to counter FDA charges (Business Standard India)
Daiichi Sankyo, which owns India s biggest drug maker, said it had formed a team with Ranbaxy Laboratories, to address the data falsification charges levied by the US Food and Drug Administration (USFDA) even as analysts foresaw more trouble for the drug maker.